Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy

Journal of Nephrology

Volumn 22, Issue 1, 2009, Pages 152-159

  Pirulli, Doroti ^a   Crovella, Sergio ^a   Ulivi, Sheila ^a   Zadro, Cristina ^a   Bertok, Sara ^a   Rendine, Sabina ^b   Scolari, Francesco ^c   Foramitti, Marina ^c   Ravani, Pietro ^d   Roccatello, Dario ^b   Savoldi, Silvana ^e   Cerullo, Giuseppina ^f   Lanzilotta, Salvatore Giovanni ^f   Bisceglia, Luigi ^g   Zelante, Leopoldo ^g   Floege, Jurgen ^h   Alexopoulos, Epstathios ⁱ   Kirmizis, Dimitrios ⁱ   Ghiggeri, Gian Marco ^j   Frascà, Giovanni ^k   Schena, Francesco Paolo ^f   Amoroso, Antonio ^b   more..

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Renal Unit   (Italy)

^d Department of General and Specialistic Medicine   (Italy)

^e Ciriè Hospital   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^h RWTH AACHEN UNIVERSITY   (Germany)

ⁱ ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^j G GASLINI INSTITUTE   (Italy)

^k OSPEDALI RIUNITI   (Italy)

more..

Author keywords

C1Ga T1; Genetic association; IgA nephropathy; Polymorphisms

Indexed keywords

CORE 1 BETA 1,3 GALACTOSYLTRANSFERASE 1; GALACTOSYLTRANSFERASE; UNCLASSIFIED DRUG; C1GALT1 PROTEIN, HUMAN; IMMUNOGLOBULIN A;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE FREQUENCY; GENE FUNCTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN GLYCOSYLATION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BLOOD; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; ITALY; MIDDLE AGED;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GALACTOSYLTRANSFERASES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; ITALY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 66349083640     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. van der Boog PJ, van Kooten C, de Fijter JW, et al. Role of macromolecular IgA in IgA nephropathy. Kidney Int. 2005;67:813-821.
2. Xu LX, Zhao MH. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int. 2005;68:167-172.
3. Hiki Y, Kokubo T, Iwase H, et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol. 1999;10:760-769.
4. Kokubo T, Hiki Y, Iwase H, et al. Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy. J Am Soc Nephrol. 1997;8:915-919.
5. Odani H, Hiki Y, Takahashi M, et al. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. Biochem Biophys Res Commun. 2000;271:268-274.
6. Van den Steen PE, Rudd PM, Wormald MR, et al. O-Linked glycosylation in focus. Trends Glycosci Glycotechnol. 2000;12:35-49.
7. Amore A, Cirina P, Conti G, et al. Glycosylation of circulating IgA in patients with IgA Nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol. 2001;12:1862-1871.
8. Kokubo T, Hiki Y, Iwase H, et al. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol. 1998;9:2048-2054.
9. Mestecky J, Tomana M, Crowley-Nowick PA, et al. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol. 1993;104:172-182.
10. Allen AC, Topham PS, Harper SJ, et al. Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant. 1997;12:701-706.
11. Iwasaki H, Zhang Y, Tachibana K, et al. Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2. J Biol Chem. 2003;278:5613-5621.
12. Ju T, Brewer K, D'Souza A, et al. Cloning and expression of human core 1 beta1,3-galactosyltransferase. J Biol Chem. 2002;277:178-186.
13. Kudo T, Iwai T, Kubota T, et al. Molecular cloning and characterization of a novel UDP-Gal:GalNAc (alpha) peptide beta 1,3-galactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan. J Biol Chem. 2002;277:47724-47731.
14. Kitagawa H, Paulson JC. Differential expression of five sialyltransferase genes in human tissues. J Biol Chem. 1994;269:17872-17878.
15. Qin W, Zhou Q, Yang LC, et al. Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression. J Intern Med. 2005;258:467-477.
16. The AceView genes. Updated March 21, 2008. Available at: http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly. Accessed January 12, 2009.
17. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475-1489.
18. Sambrook J, Russell DW. Molecular cloning: a laboratory manual. 3rd ed. Plainview, NY: Cold Spring Harbor Laboratory Press; 2001.
19. Schneider S, Roessli D, Excoffier L. Arlequin: a software for population genetics data analysis. Version 2.00. Geneva: Genetics and Biometry Lab, Department of Anthropology and Ecology, University of Geneva; 2000. Available at: http://lgb.unige.ch/arlequin/. Accessed January 12, 2009.
20. Horie A, Hiki Y, Odani H, et al. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy. Am J Kidney Dis. 2003;42:486-496.
21. Tomana M, Matousovic K, Julian BA, et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 1997;52:509-516.
22. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics. 1995;29:311-322.
23. Tomana M, Novak J, Julian BA, et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest. 1999;104:73-81.
24. Leung JC, Tang SC, Chan LY, et al. Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. Nephrol Dial Transplant. 2003;18:36-45.
25. Zarudnaya MI, Kolomiets IM, Potyahaylo AL, et al. Downstream elements of mammalian pre-mRNA polyadenylation signals: primary, secondary and higher-order structures. Nucleic Acids Res. 2003;31:1375-1386.
26. Li G-S, Zhang H, Lv J-C, et al. Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int. 2007;71:448-453.
27. Narita I, Kaneko Y, Kondo D, Goto S, Sakatsume M, Gejyo F. The genetic susceptibility to IgA nephropathy: a novel functional candidate gene for incomplete O-glycosylation of IgA1. Kidney Int. 2007;71:379-381.
28. Ju T, Cummings RD. Protein glycosylation: chaperone mutation in Tn syndrome [brief communication]. Nature. 2005;437:1252.
29. Ju T, Cummings RD. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci U S A. 2002;99:16613-16618.